Drug Development, Drug Pricing and Pharmaceutical Manufacturing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Drug Development

Drug Pricing

Pharmaceutical Manufacturing

STAT+: Pharmalittle: Mid-year price hikes for U.S. drugs reaches new heights; onetime biotech CEO Vivek Ramaswamy sparks debate at GOP debate

STAT

AUGUST 24, 2023

A new analysis of mid-year price hikes has found that, despite policy changes under the Inflation Reduction Act, drug prices are on the rise , STAT reports. Biden health officials are expected to reveal the initial list before the stock market opens Tuesday morning.

Drug Pricing

Drug Pricing Pharmaceutical Manufacturing Drug Development

Divided Congress paves way for drug price reforms on Biden’s watch

pharmaphorum

NOVEMBER 10, 2020

High drug prices was a touchstone issue in the 2016 elections and Biden has also made this a priority in his campaigning. This includes reducing drug costs to consumers in the United States. “If any of these are successful, it could materially impact profit margins for the drug manufacturers.”

Drug Pricing

Drug Pricing Vaccines Pharmaceutical Manufacturing Drug Development

Pharmacist Digest

STAT+: Pharmalittle: Mid-year price hikes for U.S. drugs reaches new heights; onetime biotech CEO Vivek Ramaswamy sparks debate at GOP debate

Divided Congress paves way for drug price reforms on Biden’s watch

Stay Connected